001     126160
005     20240228140811.0
024 7 _ |a 10.1038/leu.2015.119
|2 doi
024 7 _ |a pmid:25971364
|2 pmid
024 7 _ |a 0887-6924
|2 ISSN
024 7 _ |a 1476-5551
|2 ISSN
024 7 _ |a altmetric:4014354
|2 altmetric
037 _ _ |a DKFZ-2017-02275
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Blume, C. J.
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a p53-dependent non-coding RNA networks in chronic lymphocytic leukemia.
260 _ _ |a Basingstoke
|c 2015
|b Nature Publ. Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1523606171_31445
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Mutations of the tumor suppressor p53 lead to chemotherapy resistance and a dismal prognosis in chronic lymphocytic leukemia (CLL). Whereas p53 targets are used to identify patient subgroups with impaired p53 function, a comprehensive assessment of non-coding RNA targets of p53 in CLL is missing. We exploited the impaired transcriptional activity of mutant p53 to map out p53 targets in CLL by small RNA sequencing. We describe the landscape of p53-dependent microRNA/non-coding RNA induced in response to DNA damage in CLL. Besides the key p53 target miR-34a, we identify a set of p53-dependent microRNAs (miRNAs; miR-182-5p, miR-7-5p and miR-320c/d). In addition to miRNAs, the long non-coding RNAs (lncRNAs) nuclear enriched abundant transcript 1 (NEAT1) and long intergenic non-coding RNA p21 (lincRNA-p21) are induced in response to DNA damage in the presence of functional p53 but not in CLL with p53 mutation. Induction of NEAT1 and lincRNA-p21 are closely correlated to the induction of cell death after DNA damage. We used isogenic lymphoma cell line models to prove p53 dependence of NEAT1 and lincRNA-p21. The current work describes the p53-dependent miRNome and identifies lncRNAs NEAT1 and lincRNA-p21 as novel elements of the p53-dependent DNA damage response machinery in CLL and lymphoma.
536 _ _ |a 317 - Translational cancer research (POF3-317)
|0 G:(DE-HGF)POF3-317
|c POF3-317
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a MicroRNAs
|2 NLM Chemicals
650 _ 7 |a NEAT1 long non-coding RNA, human
|2 NLM Chemicals
650 _ 7 |a RNA, Long Noncoding
|2 NLM Chemicals
650 _ 7 |a RNA, Messenger
|2 NLM Chemicals
650 _ 7 |a TP53 protein, human
|2 NLM Chemicals
650 _ 7 |a Tumor Suppressor Protein p53
|2 NLM Chemicals
700 1 _ |a Hotz-Wagenblatt, A.
|0 P:(DE-He78)2f34b89d62d5e5c651aa1e683844b092
|b 1
|u dkfz
700 1 _ |a Hüllein, J.
|0 P:(DE-He78)c9be4ab60d1090c3d315a2ca6905e9ea
|b 2
|u dkfz
700 1 _ |a Sellner, L.
|0 P:(DE-He78)b07a76205b49e86733668b7201520d19
|b 3
|u dkfz
700 1 _ |a Jethwa, A.
|0 P:(DE-He78)7f506158c27b5827cd9021cd3dad37c8
|b 4
|u dkfz
700 1 _ |a Stolz, T.
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Slabicki, M.
|0 P:(DE-He78)7cf71173d859413d8fab2ea590f3a338
|b 6
|u dkfz
700 1 _ |a Lee, K.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Sharathchandra, A.
|b 8
700 1 _ |a Benner, A.
|0 P:(DE-He78)e15dfa1260625c69d6690a197392a994
|b 9
|u dkfz
700 1 _ |a Dietrich, S.
|0 P:(DE-He78)6333b389d0abc96ef7f2f6e049a8f8c4
|b 10
|u dkfz
700 1 _ |a Oakes, C. C.
|0 P:(DE-HGF)0
|b 11
700 1 _ |a Dreger, P.
|b 12
700 1 _ |a te Raa, D.
|b 13
700 1 _ |a Kater, A. P.
|b 14
700 1 _ |a Jauch, A.
|b 15
700 1 _ |a Merkel, O.
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Oren, M.
|b 17
700 1 _ |a Hielscher, T.
|0 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
|b 18
|u dkfz
700 1 _ |a Zenz, Thorsten
|0 P:(DE-He78)f3d5f16b49eb47520def635be98d5576
|b 19
|e Last author
|u dkfz
773 _ _ |a 10.1038/leu.2015.119
|g Vol. 29, no. 10, p. 2015 - 2023
|0 PERI:(DE-600)2008023-2
|n 10
|p 2015 - 2023
|t Leukemia
|v 29
|y 2015
|x 1476-5551
909 C O |o oai:inrepo02.dkfz.de:126160
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)2f34b89d62d5e5c651aa1e683844b092
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)c9be4ab60d1090c3d315a2ca6905e9ea
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)b07a76205b49e86733668b7201520d19
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)7f506158c27b5827cd9021cd3dad37c8
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)7cf71173d859413d8fab2ea590f3a338
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)1121dc6777ecb3a3e48075bbd16246f2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)e15dfa1260625c69d6690a197392a994
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)6333b389d0abc96ef7f2f6e049a8f8c4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)f3d5f16b49eb47520def635be98d5576
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-317
|2 G:(DE-HGF)POF3-300
|v Translational cancer research
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b LEUKEMIA : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b LEUKEMIA : 2015
920 1 _ |0 I:(DE-He78)G100-20160331
|k G100
|l Translationale Onkologie
|x 0
920 1 _ |0 I:(DE-He78)W180-20160331
|k W180
|l Bioinformatik (HUSAR)
|x 1
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l Biostatistik
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)G100-20160331
980 _ _ |a I:(DE-He78)W180-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21